- CFO Spotlights
- Profiles
- Katharyn Field
Profile
Katharyn Field
Chief Financial Officer, BioRestorative Therapies, Inc.
Former. First published here October 28, 2026; built from records as of October 28, 2026.
BioRestorative Therapies, Inc. named Anna Skowron to succeed Katharyn Field, effective August 27, 2026.1
Another profile on this site carries the same name: Katharyn Field of Advasa Holdings, Inc.. The filings do not establish that they are the same person, so the records are kept apart.
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) Services-Misc Health & Allied Services, NEC | Not stated | Former |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- August 27, 2026effective
BioRestorative Therapies, Inc. named Anna Skowron to succeed Katharyn Field, effective August 27, 2026. Profile of Anna Skowron.
[1] Filing by BioRestorative Therapies, Inc., filed with the SEC on September 2, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Current report filed with the SEC, BioRestorative Therapies, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed September 2, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Katharyn Field wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.